DaVita Inc.

DVA Healthcare Medical Care Facilities

DaVita Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.6 billion, up 6.46% from fiscal 2024.

Revenue
+4.62%
EPS
+67.0%
Free cash flow
−45.8%
Total debt
+5.07%

Quarter to September 2026, against a year earlier

189.65 5.17 −2.65%
Market cap
$12.3B
P/E
14.0×
Fwd P/E
13.0×
Dividend yield
—
F-score
6/9
Altman Z
1.49
Beneish M
−2.59
Dividend safety
n/a
Older periods Dec '25 Mar '26 Jun '26 Sep '26
P/E ratio

+8 more quarters

11.23 13.97 17.83 12.60
P/S ratio
0.62 0.75 1.03 0.79
P/FCF ratio
5.56 6.12 8.01 7.52
P/Operating CF
15.60 32.28 29.41 21.52
P/B ratio
0.00 0.00 0.00 0.00
EV/Sales
1.33 1.47 1.75 1.51
EV/EBITDA
6.57 7.25 8.62 7.57
EV/FCF
11.94 12.00 13.59 14.37
Current Ratio
1.29 1.42 1.47 1.41
Net Debt/EBITDA
12.96 15.10 13.45 15.31
Debt/Equity
(28.02) (22.49) (22.44) (30.19)
Earnings Yield
8.91% 7.16% 5.61% 7.94%
Free Cash Flow Yield
18.00% 16.35% 12.48% 13.30%
Free Cash Flow per Share
5.35 3.30 4.95 5.82
Book value per Share
(5.03) (7.07) (7.44) (5.62)
Free Cash Flow
397.13 222.53 320.92 371.25
EV/EBIT
8.87 9.74 11.50 10.06
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026